Home
Platform
Services
Brands
Locations
Careers
News
Library
Responsibility
Contact Us
Platform
Our Platform
Our Competitive Edge
Services
Preclinical Development
Clinical Development
Regulatory Affairs & Consulting
Data Sciences
Molecular Laboratory R&D Services
Microbiology and Diagnostics R&D Services
Brands
Clinglobal
About us
Our Services
Our Team
Clinvet
About us
Our Services
Our Team
Clindata
About us
Our Services
Our Team
Clinomics
About us
Our Services
Our Team
Rtilab
Locations
Careers
News
Social Media
Library
Research Models
Publications
Responsibility
Our Purpose
Our Values
Corporate Responsibility
Compliance
Contact us
Evaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra®) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs
Home
Evaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra®) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs
Megan du Randt
February 17, 2025
February 17, 2025
0 Comments
Categories:
Research Models
Post navigation
Previous
World Association for the Advancement of Veterinary Parasitology (WAAVP): Second edition of guidelines for evaluating the efficacy of anthelmintics for dogs and cats
Next
Efficacy of emodepside plus praziquantel tablets (Profender tablets for dogs) against mature and immature infections with Toxocara canis and Toxascaris leonina in dogs
